Novartis CEO calls for fixing 'distortions' in health care system ahead of slate of drug launchesCNBC • 05/21/19
Commentary: Novartis CEO says gene therapies promise to upend US health system, pricing structureCNBC • 05/17/19
Novartis (NVS) CEO Vasant Narasimhan on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 04/25/19
A Second Baby Died In A Gene Therapy Study — Slugging This Biotech StockInvestors Business Daily • 04/22/19
Novartis' BLA Acceptance Allows Entrance Into Large And Turbulent Wet AMD MarketSeeking Alpha • 04/17/19
Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New DealZacks Investment Research • 04/12/19
Novartis completed its spin-off of eye care specialist Alcon and Zogenix had a drug application rejected.The Motley Fool • 04/09/19